IC

Ikarian Capital Portfolio holdings

AUM $302M
1-Year Return 65.21%
This Quarter Return
+3.55%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$349M
AUM Growth
-$87.3M
Cap. Flow
-$46.8M
Cap. Flow %
-13.39%
Top 10 Hldgs %
42.96%
Holding
198
New
27
Increased
9
Reduced
43
Closed
22

Top Buys

1
KZR icon
Kezar Life Sciences
KZR
$17.1M
2
ZNTL icon
Zentalis Pharmaceuticals
ZNTL
$8.3M
3
PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
$6.55M
4
CLDX icon
Celldex Therapeutics
CLDX
$5.75M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$5.39M

Top Sells

1
APLS icon
Apellis Pharmaceuticals
APLS
$11.5M
2
ITCI
Intra-Cellular Therapies Inc.
ITCI
$7.89M
3
CMPS
Compass Pathways
CMPS
$6.85M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
$6.66M
5
XENE icon
Xenon Pharmaceuticals
XENE
$6.2M

Sector Composition

1 Healthcare 97.67%
2 Consumer Staples 0.57%
3 Technology 0.35%
4 Financials 0.21%
5 Real Estate 0.11%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ALLK
151
DELISTED
Allakos
ALLK
– –
-31,526
Closed -$3.34M
APLS icon
152
Apellis Pharmaceuticals
APLS
$3.62B
– –
-347,545
Closed -$11.5M
ARKG icon
153
ARK Genomic Revolution ETF
ARKG
$1.05B
– –
-40,961
Closed -$3.06M
ATHA icon
154
Athira Pharma
ATHA
$15.3M
– –
0
– –
AVIR icon
155
Atea Pharmaceuticals
AVIR
$264M
– –
0
– –
AZN icon
156
AstraZeneca
AZN
$254B
– –
0
– –
BCAB icon
157
BioAtla
BCAB
$29.3M
– –
-196,400
Closed -$5.78M
BCRX icon
158
BioCryst Pharmaceuticals
BCRX
$1.74B
– –
0
– –
BMRN icon
159
BioMarin Pharmaceuticals
BMRN
$10.9B
– –
0
– –
CMPS
160
Compass Pathways
CMPS
$489M
– –
-229,202
Closed -$6.85M
COGT icon
161
Cogent Biosciences
COGT
$1.81B
– –
-30,727
Closed -$258K
CRSP icon
162
CRISPR Therapeutics
CRSP
$4.8B
– –
-27,968
Closed -$3.13M
DCTH icon
163
Delcath Systems
DCTH
$388M
– –
-44,857
Closed -$468K
EDIT icon
164
Editas Medicine
EDIT
$227M
– –
0
– –
ELAN icon
165
Elanco Animal Health
ELAN
$8.68B
– –
0
– –
IMVT icon
166
Immunovant
IMVT
$2.81B
– –
-83,046
Closed -$722K
KNSA icon
167
Kiniksa Pharmaceuticals
KNSA
$2.63B
– –
-59,422
Closed -$677K
KOD icon
168
Kodiak Sciences
KOD
$452M
– –
0
– –
KRYS icon
169
Krystal Biotech
KRYS
$4.33B
– –
0
– –
MRK icon
170
Merck
MRK
$210B
– –
0
– –
OBIO icon
171
Orchestra BioMed
OBIO
$148M
– –
-197,173
Closed -$1.95M
PTGX icon
172
Protagonist Therapeutics
PTGX
$3.71B
– –
0
– –
QNCX icon
173
Quince Therapeutics
QNCX
$86.2M
– –
-20,160
Closed -$1.85M
RCUS icon
174
Arcus Biosciences
RCUS
$1.23B
– –
0
– –
RLAY icon
175
Relay Therapeutics
RLAY
$690M
– –
0
– –
4 5 6
7
8